Press Release Archive
-
New Study Suggests Surgical Stapler May Play Important Role in Reducing Common Complications Associated with Lung SurgeryNew Study Suggests Surgical Stapler May Play Important Role in Reducing Common Complications Associated with Lung Surgery
-
U.S. FDA Approves IMBRUVICA® (ibrutinib) Plus Obinutuzumab as First Non-Chemotherapy Combination Regimen for Treatment-Naïve Patients with Chronic Lymphocytic LeukemiaU.S. FDA Approves IMBRUVICA® (ibrutinib) Plus Obinutuzumab as First Non-Chemotherapy Combination Regimen for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia
-
Johnson & Johnson Reports 2018 Fourth-Quarter Results:Johnson & Johnson Reports 2018 Fourth-Quarter Results:
-
Johnson & Johnson Announces Research Study with Apple Watch to Help Improve AFib Outcomes Including Stroke PreventionJohnson & Johnson Announces Research Study with Apple Watch to Help Improve AFib Outcomes Including Stroke Prevention
-
Dr. Paul Janssen Award for Biomedical Research Issues 2019 Call for Nominations to Celebrate Champions of ScienceDr. Paul Janssen Award for Biomedical Research Issues 2019 Call for Nominations to Celebrate Champions of Science
-
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2019Johnson & Johnson Announces Quarterly Dividend for First Quarter 2019
-
Johnson & Johnson to Participate in 37th Annual JP Morgan Health Care ConferenceJohnson & Johnson to Participate in 37th Annual JP Morgan Health Care Conference
-
Johnson & Johnson to Host
Investor Conference Call on Fourth-Quarter ResultsJohnson & Johnson to Host
Investor Conference Call on Fourth-Quarter Results -
Johnson & Johnson Announces $5 Billion Share Repurchase ProgramJohnson & Johnson Announces $5 Billion Share Repurchase Program
-
Statement on Reuters Talc ArticleStatement on Reuters Talc Article